The results of screening for prostate cancer in men aged up to 55 years
- Authors: Tarend D.T1, Sukonko O.G2, Krasny S.A2, Semenov S.A.2, Karman A.V2
-
Affiliations:
- Minsk Regional Clinical Hospital
- N.N. Alexandrov National Cancer Centre
- Issue: Vol 21, No 1-2 (2016)
- Pages: 47-50
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40309
- DOI: https://doi.org/10.18821/1028-9984-2015-21-1-47-50
- ID: 40309
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
D. T Tarend
Minsk Regional Clinical HospitalMinsky distr., 223041, Belarus
O. G Sukonko
N.N. Alexandrov National Cancer CentreMinsk, 223040, Belarus
S. A Krasny
N.N. Alexandrov National Cancer CentreMinsk, 223040, Belarus
Svyataslau A. Semenov
N.N. Alexandrov National Cancer Centre
Email: SemenovSv3@gmail.com
urologist, Department of the urology Minsk, 223040, Belarus
A. V Karman
N.N. Alexandrov National Cancer CentreMinsk, 223040, Belarus
References
- Океанов А.Е., Моисеев П.И., Левин Л.Ф. Статистика онкологических заболеваний в Республике Беларусь (2004-2013). Минск: РНПЦ ОМР им. Н.Н. Александрова; 2014.
- Океанов А.Е., Моисеев П.И., Красный С.А., Поляков С.Л., Евмененко А.А. Рак предстательной железы в Республике Беларусь. Онкологический журнал. 2012; 1: 15-24.
- Суконко О.Г., Красный С.А., Океанов А.Е., Моисеев П.И., Поляков С.Л. Рак предстательной железы в Республике Беларусь: вчера, сегодня, завтра. Здравоохранение. 2013; 11: 34-42.
- Heidenreich A., Abrahamsson P., Artibani W., Catto J., Montorsi F., Van Poppel H. et al. Early detection of prostate cancer: european association of urology recommendation. Eur. Urol. 2013; 64 (3): 347-54.
- Antenor J.A., Han M., Roehl K.A., Nadler R.B., Catalona W.J. Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study. J. Urol. 2004; 172: 90-3.
- Takechi H., Ito K., Yamamoto T., Ohi M., Kubota H. Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less. Prostate. 2003; 57: 8-13.
- Roobol M.J., Roobol D.W., Schröder F.H. Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/ml or less in a population-based screening setting? (ERSPC, section Rotterdam). Urology. 2005; 65: 343-6.